Investing in the future: Improving cancer biomarker testing and cancer diagnosis for sustainable healthcare is a new white paper co-authored by a team of medical and patient advocacy experts, including representatives from the ECPC, Oncohealth Institute and Fight Bladder Cancer.

The white paper calls for increased access to cancer biomarker testing, to identify those who will benefit most from precision cancer medicines.